Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors

Michael A. Nauck; Juris J. Meier; Matthew A. Cavender; Mirna Abd El Aziz; Daniel J. Drucker

doi:10.1161/circulationaha.117.028136

Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors

Circulation ◽

10.1161/circulationaha.117.028136 ◽

2017 ◽

Vol 136 (9) ◽

pp. 849-870 ◽

Cited By ~ 200

Author(s):

Michael A. Nauck ◽

Juris J. Meier ◽

Matthew A. Cavender ◽

Mirna Abd El Aziz ◽

Daniel J. Drucker

Keyword(s):

Clinical Outcomes ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Receptor Agonists ◽

Cardiovascular Actions ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study

International Journal of Cardiology ◽

10.1016/j.ijcard.2021.02.011 ◽

2021 ◽

Author(s):

Irene Santos-Pardo ◽

Bo Lagerqvist ◽

Viveca Ritsinger ◽

Nils Witt ◽

Anna Norhammar ◽

...

Keyword(s):

Observational Study ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Receptor Agonists ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Patients With Diabetes ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Nationwide Observational Study

Download Full-text

Effects of dipeptidyl peptidase-4 inhibitors in a type 2 diabetes patient with failure of glucagon-like peptide-1 receptor agonists (二肽基肽酶-4抑制剂在1名使用胰高血糖素样肽-1受体激动剂治疗失败的2型糖尿病患者中的作用)

Journal of Diabetes ◽

10.1111/1753-0407.12077 ◽

2013 ◽

Vol 6 (2) ◽

pp. 164-166 ◽

Cited By ~ 2

Author(s):

Yufan Wang ◽

Li Zhao ◽

Qianfang Huang ◽

Yongde Peng

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Diabetes Patient ◽

Dipeptidyl Peptidase 4 ◽

Receptor Agonists ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2012.01603.x ◽

2012 ◽

Vol 14 (8) ◽

pp. 762-767 ◽

Cited By ~ 125

Author(s):

C. F. Deacon ◽

E. Mannucci ◽

B. Ahrén

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Receptor Agonists ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd013650 ◽

2020 ◽

Author(s):

Takayoshi Kanie ◽

Atsushi Mizuno ◽

Daisuke Yoneoka ◽

Wilson Wai San Tam ◽

Jakub Morze ◽

...

Keyword(s):

Cardiovascular Disease ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Receptor Agonists ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Dipeptidyl Peptidase-4 Inhibitors, and Risk of Hospitalization

The American Journal of Cardiology ◽

10.1016/j.amjcard.2021.11.013 ◽

2021 ◽

Author(s):

Beini Lyu ◽

Morgan E. Grams ◽

Alex Chang ◽

Lesley A. Inker ◽

Josef Coresh ◽

...

Keyword(s):

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Receptor Agonists ◽

Sodium Glucose Cotransporter ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Incorporating Incretin-Based Therapies Into Clinical Practice: Differences Between Glucagon-Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors

Mayo Clinic Proceedings ◽

10.4065/mcp.2010.0469 ◽

2010 ◽

Vol 85 (12) ◽

pp. S27-S37 ◽

Cited By ~ 32

Author(s):

Jaime A. Davidson

Keyword(s):

Clinical Practice ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Receptor Agonists ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists: a Review for the General Cardiologist

Current Cardiology Reports ◽

10.1007/s11886-020-01355-5 ◽

2020 ◽

Vol 22 (10) ◽

Author(s):

Kershaw V. Patel ◽

Ashish Sarraju ◽

Ian J. Neeland ◽

Darren K. McGuire

Keyword(s):

Cardiovascular Effects ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Receptor Agonists ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on colorectal cancer incidence and its precursors

European Journal of Clinical Pharmacology ◽

10.1007/s00228-016-2068-3 ◽

2016 ◽

Vol 72 (8) ◽

pp. 1013-1023 ◽

Cited By ~ 6

Author(s):

Phyo T. Htoo ◽

John B. Buse ◽

Mugdha Gokhale ◽

M. Alison Marquis ◽

Virginia Pate ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Incidence ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Receptor Agonists ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Colorectal Cancer Incidence ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors

Pharmacology & Therapeutics ◽

10.1016/j.pharmthera.2009.06.002 ◽

2009 ◽

Vol 124 (1) ◽

pp. 113-138 ◽

Cited By ~ 113

Author(s):

E.J. Verspohl

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Incretin Hormone ◽

Dipeptidyl Peptidase 4 ◽

Novel Therapeutics ◽

Receptor Agonists ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series

Pharmacy Practice ◽

10.18549/pharmpract.2019.4.1588 ◽

2019 ◽

Vol 17 (4) ◽

pp. 1588 ◽

Cited By ~ 2

Author(s):

Estela Lajthia ◽

John D. Bucheit ◽

Pramit A. Nadpara ◽

Dave L. Dixon ◽

Lauren M. Caldas ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Case Series ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Receptor Agonists ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text